| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $35.8M | -7.2% |
| Cost of Revenue | $20.7M | -34.3% |
| Gross Profit | $15.1M | +113.5% |
| R&D Expense | $13.7M | +12.7% |
| SG&A Expense | $17.9M | +2.9% |
| Operating Income | -$16.5M | +26.5% |
| Pre-tax Income | -$15.4M | +31.4% |
| Income Tax | $1.3M | +130.8% |
| Net Income | -$17.1M | -164.1% |
| EPS (Basic) | -$0.68 | -162.4% |
| EPS (Diluted) | -$0.68 | -162.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $68.9M | -32.9% |
| Short-term Investments | $25.5M | +149.9% |
| Accounts Receivable | $15.8M | +11.0% |
| Inventory | $30.0M | +418.1% |
| Current Assets | $142.2M | +5.4% |
| Total Assets | $173.1M | +9.7% |
| Current Liabilities | $26.0M | +31.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.4M | -2774.1% |
| Investing Cash Flow | -$28.4M | -139.9% |
| Financing Cash Flow | $2.4M | +24.3% |
| Stockholders' Equity |
| $123.5M |
| -7.9% |